Our friends at Helix Health, a medical practice with expertise in genomic medicine are hosting a free 90-minute webcast this Wednesday, May 21, 2008 from 1:00-2:30 PM EDT on: How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer.
To register, point your browser here: http://event.netbriefings.com/event/helixhealth/register.html.
Join NPR’s David Ewing Duncan, author Jessica Queller and a panel of medical and legal experts in a 90-minute webcast on genetic testing, genomic medicine and breast & ovarian cancer to learn some of the best practices in genomic medicine today from:
Steven A.R. Murphy, MD – Clinical Genetics Fellow at Yale School of Medicine, and Helix Health’s Managing Partner will moderate the panel.
Barbra A. Ward, MD – Director, The Breast Center of Greenwich Hospital; the principal investigator of the STAR Trial at the Yale Cancer Center; prior director of the Yale Comprehensive Breast Care Center and currently a surgical oncologist affiliated with Yale-New Haven Health System.
Jessica Queller – author of Pretty Is What Changes, an account of her valiant decision to accept the results of genetic testing and her difficult decision to undergo a prophylactic double mastectomy. Television writer for Felicity, The Gilmore Girls and One Tree Hill. Writer/producer on Gossip Girl.
Jennifer Ibrahim, MD – clinical geneticist specializing in preconception genetics as well span as familial cancer syndromes.
David Ewing Duncan – bestselling author of Masterminds: Genius, DNA and the Quest to Rewrite Life; Chief Correspondent and co-host of National Public Radio’s Biotech Nation”; Contributing Editor and Columnist, Portfolio; Ditto, Wired; Director, Center for Life Sciences Policy, UC Berkeley; author to articles and short stories, and a television, radio and film producer and correspondent.
Gary E. Marchant – Ph.D. J.D., Lincoln Professor of Emerging Technologies, Law & Ethics, Sandra Day O’Connor College of Law. Executive Director, Center for Law, Science & Technology, Professor, School of Life Sciences Arizona State University.
More information is available on the Helix Health website.
Filed under: Personalized Medicine, Pharmacogenetics
